Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ritz

Showing results (181-190 of 297) with videos related to

Pageof 30
Sort By:
The Journal of Experimental Medicine|November 1, 1983
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector functionT Hercend, S Meuer, A Brennan, et al.
The Journal of Experimental Medicine|January 1, 1983
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA)P Hokland, P Rosenthal, J D Griffin, et al.
Journal of Clinical Microbiology|September 1, 1993
Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenemG L Cooper, A Louie, A L Baltch, et al.
Blood|January 15, 1992
Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantationR J Soiffer, C Murray, K Cochran, et al.
Science (New York, N.Y.)|June 28, 1985
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clonesJ Ritz, T J Campen, R E Schmidt, et al.
Blood|March 15, 1993
Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemiaA L Billett, E Kornmehl, N J Tarbell, et al.
Bone Marrow Transplantation|December 1, 1990
Autoimmune pancytopenia following allogeneic bone marrow transplantationT R Klumpp, M A Caligiuri, S N Rabinowe, et al.
Cellular Immunology|July 1, 1984
Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structureT Hercend, S Meuer, A Brennan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanomaR J Soiffer, P B Chapman, C Murray, et al.
Progress in Hematology|January 1, 1987
Monoclonal antibodies: their use in bone marrow transplantationK C Anderson, L M Nadler, T Takvorian, et al.
Pageof 30

Showing results (181-190 of 297) with videos related to

Sort By:
Pageof 30
The Journal of Experimental Medicine|November 1, 1983
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector functionT Hercend, S Meuer, A Brennan, et al.
The Journal of Experimental Medicine|January 1, 1983
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA)P Hokland, P Rosenthal, J D Griffin, et al.
Journal of Clinical Microbiology|September 1, 1993
Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenemG L Cooper, A Louie, A L Baltch, et al.
Blood|January 15, 1992
Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantationR J Soiffer, C Murray, K Cochran, et al.
Science (New York, N.Y.)|June 28, 1985
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clonesJ Ritz, T J Campen, R E Schmidt, et al.
Blood|March 15, 1993
Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemiaA L Billett, E Kornmehl, N J Tarbell, et al.
Bone Marrow Transplantation|December 1, 1990
Autoimmune pancytopenia following allogeneic bone marrow transplantationT R Klumpp, M A Caligiuri, S N Rabinowe, et al.
Cellular Immunology|July 1, 1984
Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structureT Hercend, S Meuer, A Brennan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanomaR J Soiffer, P B Chapman, C Murray, et al.
Progress in Hematology|January 1, 1987
Monoclonal antibodies: their use in bone marrow transplantationK C Anderson, L M Nadler, T Takvorian, et al.
Pageof 30